Cetuximab plus cisplatin in patients with recurrent or metastatic nasopharyngeal carcinoma.
2014
e17035 Background: To evaluate efficacy and toxicity of cetuximab plus cisplatin in recurrent or metastatic nasopharyngeal carcinoma (NPC) after previous platinum based chemotherapy Methods: An ope...
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI